Short answer: no—hyperbaric oxygen therapy is not a standard or proven treatment for pulmonary fibrosis.
What pulmonary fibrosis involves
Pulmonary Fibrosis causes progressive scarring of lung tissue, which makes it harder for oxygen to pass into the bloodstream. Over time, this leads to shortness of breath and reduced oxygen levels.
Why HBOT isn’t a good fit
Hyperbaric Oxygen Therapy increases oxygen levels in the blood temporarily by delivering oxygen under pressure. However:
- It does not reverse or stop lung scarring
- The underlying problem in pulmonary fibrosis is structural damage, not just low oxygen
- There’s no strong clinical evidence showing HBOT improves outcomes in this condition
In some cases, the pressure changes could even be uncomfortable or risky for people with significant lung disease.
What is used instead
Treatment for pulmonary fibrosis typically focuses on:
- Medications that slow disease progression
- Supplemental oxygen therapy (at normal pressure)
- Pulmonary rehabilitation (breathing exercises, conditioning)
- In advanced cases, lung transplant evaluation
When oxygen therapy does help
Regular oxygen therapy (not hyperbaric) can:
- Improve breathing comfort
- Increase activity tolerance
- Support overall quality of life
Bottom line
HBOT may sound appealing because it delivers more oxygen, but for pulmonary fibrosis it doesn’t address the root problem and isn’t recommended as a treatment.
